{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:08:13Z","timestamp":1735880893943,"version":"3.32.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":10256,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1017\/s1041610296002918","type":"journal-article","created":{"date-parts":[[2004,3,10]],"date-time":"2004-03-10T10:34:58Z","timestamp":1078914898000},"page":"597-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Study on Schizophrenia"],"prefix":"10.1016","volume":"8","author":[{"given":"Robert","family":"Howard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610296002918_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.166.2.205","article-title":"Psychotic states arising in late life (late paraphrenia): Psychopathology and nosology","volume":"166","author":"Almeida","year":"1995","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00431773","article-title":"Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients","volume":"87","author":"Altamura","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1017\/S1041610296002918_bb0015","first-page":"223","article-title":"Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia","volume":"10","author":"Altamura","year":"1990","journal-title":"International Journal of Clinical Pharmacology Research"},{"key":"10.1017\/S1041610296002918_bb0020","first-page":"364","article-title":"Clozapine in the treatment of psychosis in an 82-year- old woman","volume":"12","author":"Bajulaiye","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1017\/S1041610296002918_bb0025","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1001\/jama.1978.03280450032019","article-title":"High- and low-potency neuroleptics in elderly psychiatric patients","volume":"239","author":"Branchey","year":"1978","journal-title":"Journal of the American Medical Association"},{"key":"10.1017\/S1041610296002918_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1532-5415.1978.tb02400.x","article-title":"Loxapine succinate as a neuroleptic agent: Evaluation in two populations of elderly psychiatric patients","volume":"26","author":"Branchey","year":"1978","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610296002918_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1017\/S0924933800003023","article-title":"What do we know about the aetiology of late-onset schizophrenia?","volume":"7","author":"Castle","year":"1992","journal-title":"European Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1017\/S0033291700022194","article-title":"The neurodevelopmental basis of sex differences in schizophrenia","volume":"21","author":"Castle","year":"1991","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610296002918_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/j.1875-9114.1994.tb02819.x","volume":"14","author":"Cohen","year":"1994","journal-title":"Risperidone. Pharmacotherapy"},{"key":"10.1017\/S1041610296002918_bb0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1532-5415.1988.tb01777.x","article-title":"Late onset schizophrenia-like illness","volume":"36","author":"Craig","year":"1988","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610296002918_bb0055","first-page":"144","article-title":"Psychosis in neurologic disease: Neurobiology and pathogenesis","volume":"5","author":"Cummings","year":"1992","journal-title":"Neuropsychiatry, Neuropsychology and Behavioural Neurology"},{"key":"10.1017\/S1041610296002918_bb0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003495-197714040-00002","article-title":"Antipsychotic drugs: Clinical pharmacology and therapeutic use","volume":"14","author":"Davis","year":"1977","journal-title":"Drugs"},{"issue":"Suppl. B","key":"10.1017\/S1041610296002918_bb0065","first-page":"88","article-title":"The effects of clozapine on neurocognition: An overview","volume":"55","author":"Goldberg","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/schbul\/14.1.39","article-title":"Late-onset schizophrenia: An overview","volume":"14","author":"Harris","year":"1988","journal-title":"Schizophrenia Bulletin"},{"key":"10.1017\/S1041610296002918_bb0075","series-title":"Presented at International Symposium of Psychogeriatrics","article-title":"Risperidone (R64 766) in the treatment of behavioural symptoms in psychogeriatric patients: Pilot clinical investigation","author":"Heylen","year":"1988"},{"key":"10.1017\/S1041610296002918_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1532-5415.1965.tb00574.x","article-title":"Behavioral improvement in the older schizophrenic patient: Drug and social therapies","volume":"13","author":"Honigfeld","year":"1965","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610296002918_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1017\/S0033291700027379","article-title":"Phenomenology, demography and diagnosis in late paraphrenia","volume":"24","author":"Howard","year":"1994","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610296002918_bb0090","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1192\/bjp.163.3.352","article-title":"A comparative study of470 cases of early and late-onset schizophrenia","volume":"163","author":"Howard","year":"1993","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0095","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/gps.930070908","article-title":"Which factors affect treatment response in late paraphrenia?","volume":"7","author":"Howard","year":"1992","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/gps.930090509","article-title":"Charles Bonnet syndrome plus: Complex visual hallucinations of Charles Bonnet type in late paraphrenia","volume":"9","author":"Howard","year":"1994","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0105","first-page":"677","article-title":"Successful treatment of Charles Bonnet syndrome type visual hallucinosis with low-dose risperidone","volume":"9","author":"Howard","year":"1994","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0447.1993.tb03480.x","article-title":"Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations","volume":"88","author":"Hoyberg","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610296002918_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/gps.930040107","article-title":"Late paraphrenia: A follow-up study","volume":"4","author":"Hymas","year":"1989","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0193-953X(18)30513-6","article-title":"Late-onset schizophrenia: Studying clinical validity","volume":"11","author":"Jeste","year":"1988","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1017\/S1041610296002918_bb0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/schbul\/19.4.817","article-title":"Treatment of late-life schizophrenia with neuroleptics","volume":"19","author":"Jeste","year":"1993","journal-title":"Schizophrenia Bulletin"},{"key":"10.1017\/S1041610296002918_bb0130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00449128","article-title":"Serum neuroleptic concentrations and tardive dyskinesia","volume":"76","author":"Jeste","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1017\/S1041610296002918_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1192\/bjp.123.5.519","article-title":"The side-effects of fluphenazine decanoate","volume":"123","author":"Johnson","year":"1973","journal-title":"British Journal of Psychiatry"},{"issue":"Suppl. 13","key":"10.1017\/S1041610296002918_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1192\/S0007125000296311","article-title":"Disabilities and circumstances of schizophrenic patients: A follow-up study. III. Clinical findings. Abnormalities of the mental state and movement disorders and their correlates","volume":"759","author":"Johnstone","year":"1991","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0145","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatmentresistant schizophrenic: A double blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(94)92696-4","volume":"343","author":"Livingstone","year":"1994","journal-title":"Risperidone. Lancet"},{"key":"10.1017\/S1041610296002918_bb0155","first-page":"348","article-title":"Psychiatric disorders in elderly Nigerians","volume":"37","author":"Makanjuloa","year":"1985","journal-title":"Tropical and Geographical Medicine"},{"key":"10.1017\/S1041610296002918_bb0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1176\/ajp.151.6.825","article-title":"Risperidone in the treatment of schizophrenia","volume":"151","author":"Marder","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0165","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0140-6736(94)92511-9","article-title":"Risperidone for hallucinations in levodopa-treated Parkinson\u2019s disease patients","volume":"343","author":"Meco","year":"1994","journal-title":"Lancet"},{"key":"10.1017\/S1041610296002918_bb0170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0447.1990.tb05313.x","article-title":"Pharmacokinetics of remoxipride in elderly psychotic patients","volume":"358","author":"Movin","year":"1990","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610296002918_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1041610292001017","article-title":"Safety and effectiveness of low-dose clozapine in psychogeriatric patients: A preliminary study","volume":"4","author":"Oberholzer","year":"1992","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610296002918_bb0180","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/ajp.146.12.1568","article-title":"A chart review study of late-onset and early-onset schizophrenia","volume":"146","author":"Pearlson","year":"1989","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0185","series-title":"Developments in dementia and functional disorders in the elderly","first-page":"151","article-title":"Novel antipsychotics in the elderly","author":"Phanjoo","year":"1995"},{"key":"10.1017\/S1041610296002918_bb0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0447.1990.tb05314.x","article-title":"Remoxipride versus thioridazine in elderly psychotic patients","volume":"358","author":"Phanjoo","year":"1990","journal-title":"Acta Psychiatrica Scandinavica, Suppl."},{"year":"1965","series-title":"The clinical psychiatry of late life","author":"Post","key":"10.1017\/S1041610296002918_bb0195"},{"year":"1966","series-title":"Persistent persecutory states of the elderly","author":"Post","key":"10.1017\/S1041610296002918_bb0200"},{"key":"10.1017\/S1041610296002918_bb0205","series-title":"Handbook of mental health and aging","first-page":"68","article-title":"Paranoid, schizophrenia-like and schizophrenic states in the aged","author":"Post","year":"1980"},{"key":"10.1017\/S1041610296002918_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.310.6979.575","article-title":"Drug treatment of Parkinson\u2019s disease","volume":"310","author":"Quinn","year":"1995","journal-title":"British Medical Journal"},{"key":"10.1017\/S1041610296002918_bb0215","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0010-440X(84)90060-9","article-title":"Can schizophrenia begin after age 44?","volume":"25","author":"Rabins","year":"1984","journal-title":"Comprehensive Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0220","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1532-5415.1979.tb01727.x","article-title":"Fluphenazine enanthate in the outpatient treatment of late paraphrenia","volume":"27","author":"Raskind","year":"1979","journal-title":"Journal of the American Geriatrics Society"},{"issue":"Suppl","key":"10.1017\/S1041610296002918_bb0225","first-page":"17","article-title":"Antipsychotic drugs and the elderly","volume":"47","author":"Raskind","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1977.01770130045004","article-title":"Fluphenazine decanoate and fluphenazine hydrochloride given orally and placebo in remitted schizophrenics","volume":"34","author":"Rifkin","year":"1977","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00441948","article-title":"Hallucinogenic drug interactions at human brain 5-HT2 receptors: Implications for treating LSD-induced hallucinogenesis","volume":"98","author":"Sadzot","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1017\/S1041610296002918_bb0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00380972","article-title":"Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine","volume":"235","author":"Scholz","year":"1985","journal-title":"European Archives of Psychiatry and Neurological Sciences"},{"key":"10.1017\/S1041610296002918_bb0245","first-page":"603","article-title":"Evaluation of drug-related movement disorders in the aged","volume":"24","author":"Schooler","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1017\/S1041610296002918_bb0250","series-title":"Principles and practice of geriatric psychiatry","first-page":"685","article-title":"Pharmacological treatment of schizophrenia and delusional disorder of late life","volume":"pp","author":"Tran-Johnson","year":"1994"},{"key":"10.1017\/S1041610296002918_bb0255","series-title":"Clinics in geriatric medicine","first-page":"408","article-title":"Late life schizophrenia and its treatment: The pharmacologic issues in older schizophrenic patients","author":"Tran-Johnson","year":"1992"},{"key":"10.1017\/S1041610296002918_bb0260","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1532-5415.1971.tb02580.x","article-title":"Haloperidol versus thioridazine for hospitalised psychogeriatric patients: Double-blind study","volume":"19","author":"Tsuang","year":"1971","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610296002918_bb0265","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(94)90542-8","article-title":"Risperidone-induced neuroleptic malignant syndrome","volume":"344","author":"Webster","year":"1994","journal-title":"Lancet"},{"key":"10.1017\/S1041610296002918_bb0270","first-page":"373","article-title":"Clozapine treatmentof psychosis in Parkinson\u2019sdisease: A report of 5 consecutive cases","volume":"53","author":"Wolk","year":"1992","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0275","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1212\/WNL.40.5.832","article-title":"Clozapine in the treatmentof parkinsonian patients with dopaminomimetic psychosis","volume":"40","author":"Wolters","year":"1990","journal-title":"Neurology"},{"year":"1992","series-title":"The ICD-10 classification of mental and behavioral disorders","author":"World Health Organization","key":"10.1017\/S1041610296002918_bb0280"},{"key":"10.1017\/S1041610296002918_bb0285","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/ajp.139.2.174","article-title":"Serum level monitoring of thiothixene in schizophrenia: Acute single-dose levels at fixed doses","volume":"139","author":"Yesavage","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610296002918_bb0290","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0140-6736(93)90327-D","article-title":"Ondansetron for hallucinosis in advanced Parkinson\u2019s disease","volume":"341","author":"Zoldan","year":"1993","journal-title":"Lancet"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610296002918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T06:05:06Z","timestamp":1735797906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["S1041610224000838"],"URL":"https:\/\/doi.org\/10.1017\/s1041610296002918","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[1996,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on Schizophrenia","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610296002918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}